Pepsin powder, a proteolytic enzyme widely applied in pharmaceuticals, diagnostics, and food processing, has carved out a niche in the global enzyme market. The sector is poised for robust expansion, fueled by rising demand for peptide‑based therapeutics and growing interest in health‑supplement formulations.
Global Pepsin Powder Market – View in Detailed Research Report
Market Size & Growth
The global Pepsin Powder market was valued at USD 27 million in 2023 and is expected to reach USD 71.92 million by 2032, registering a CAGR of 11.50% over the forecast period. In North America, the market stood at USD 8.49 million in 2023 and is growing at a CAGR of 9.86% from 2025 to 2032.
Product Definition
Pepsin is an aspartic acid hydrolase released as pepsinogen by gastric chief cells. Upon activation, it cleaves dietary proteins into peptides, making it indispensable in pharmaceutical formulations, diagnostic assays, and nutritional supplements.
🔟 10. BASF
Headquarters: Ludwigshafen, Germany
Key Offering: Pepsin Powder (High Activity), Enzyme Solutions for Food & Pharma
BASF leverages its extensive biochemical research portfolio to deliver high‑purity pepsin for pharmaceutical manufacturing and food processing. The company’s focus on scalable production and stringent quality controls positions it as a reliable supplier in the global enzyme market.
Sustainability & Growth Initiatives:
- Investing in green bioreactors to reduce carbon footprint
- Expanding downstream integration with pharmaceutical contract manufacturers
- R&D into enzyme variants with lower environmental impact
9️⃣ 9. Johnson & Johnson
Headquarters: New Brunswick, USA
Key Offering: Pepsin Powder for Diagnostic Kits, Peptide Synthesis
Johnson & Johnson’s enzymatic division supplies pepsin for diagnostic applications, including enzyme‑linked immunosorbent assays. The firm’s robust R&D pipeline aims to enhance enzyme stability under diverse storage conditions.
Sustainability & Growth Initiatives:
- Adopting renewable energy sources across manufacturing sites
- Partnering with academic institutions to develop next‑generation enzymes
- Implementing circular economy practices in packaging
8️⃣ 8. Chongqing Qquanxin Xiangsheng
Headquarters: Chongqing, China
Key Offering: Pepsin Powder (High Activity), Enzymes for Food & Pharma
Chongqing Qquanxin Xiangsheng focuses on high‑activity pepsin, catering to the rapidly expanding Chinese pharmaceutical and food industries. The company’s production capacity has expanded through strategic acquisitions.
Sustainability & Growth Initiatives:
- Implementing waste‑to‑energy solutions in production facilities
- Expanding product portfolio to include low‑activity pepsin for specialty applications
- Strengthening supply chain resilience through regional diversification
7️⃣ 7. Sichuan Biosyn Pharmaceutical
Headquarters: Chengdu, China
Key Offering: Pepsin Powder for Pharmaceutical & Food Applications
Sichuan Biosyn has built a reputation for delivering consistent enzyme quality across the Asian market. Its vertical integration ensures control over raw material sourcing and downstream processing.
Sustainability & Growth Initiatives:
- Adopting ISO 14001 environmental management systems
- Investing in bioreactor automation to improve yield and reduce waste
- Collaborating with local universities for talent development
6️⃣ 6. Sichuan Deebio Pharmaceutical
Headquarters: Chengdu, China
Key Offering: Pepsin Powder (Low Activity), Enzymes for Diagnostics
With a strong foothold in diagnostic enzyme markets, Sichuan Deebio supplies low‑activity pepsin for immunoassays and other analytical methods. The company’s focus on precision manufacturing aligns with stringent regulatory requirements.
Sustainability & Growth Initiatives:
- Implementing energy‑efficient fermentation processes
- Expanding product range to include enzyme cocktails
- Engaging in public‑private partnerships for research funding
5️⃣ 5. Feideli Pharmaceutical
Headquarters: Shanghai, China
Key Offering: Pepsin Powder for Pharmaceutical Manufacturing
Feideli’s high‑purity pepsin is widely used in peptide synthesis and drug formulation. The firm’s strategic alliances with contract manufacturers enable rapid market penetration.
Sustainability & Growth Initiatives:
- Adopting green chemistry principles in enzyme production
- Investing in digital traceability for supply chain transparency
- Developing enzyme variants with enhanced thermal stability
4️⃣ 4. Kin Master
Headquarters: São Paulo, Brazil
Key Offering: Pepsin Powder for Food & Pharmaceutical Uses
Kin Master’s pepsin is favored in Latin American food processing and pharmaceutical sectors. The company’s focus on regional distribution networks supports its market penetration.
Sustainability & Growth Initiatives:
- Implementing water‑recycling systems in production
- Expanding product lines to include specialty enzymes
- Collaborating with local research institutions for enzyme engineering
3️⃣ 3. Biolaxi Corporation
Headquarters: Mumbai, India
Key Offering: Pepsin Powder for Pharmaceutical & Health Supplement Applications
Biolaxi’s pepsin is a staple ingredient in peptide‑based nutraceuticals. The company’s emphasis on cost‑effective production has made it a preferred supplier in emerging markets.
Sustainability & Growth Initiatives:
- Adopting renewable energy sources across manufacturing sites
- Optimizing fermentation parameters for higher yield
- Investing in quality‑by‑design to meet international standards
2️⃣ 2. Mitushi Pharma
Headquarters: New Delhi, India
Key Offering: Pepsin Powder for Pharmaceutical Manufacturing
Mitushi Pharma delivers high‑purity pepsin for peptide synthesis and drug formulation. Its strong regulatory compliance framework ensures consistent supply to global pharmaceutical clients.
Sustainability & Growth Initiatives:
- Implementing waste‑to‑energy solutions in production
- Expanding production capacity through strategic acquisitions
- Investing in digital process monitoring for quality assurance
1️⃣ 1. A. Constantino & C.
Headquarters: Turin, Italy
Key Offering: Pepsin Powder (High & Low Activity), Enzyme Solutions for Food & Pharma
A. Constantino & C. has positioned itself as a key player in European enzyme markets, offering pepsin in both high and low activity grades. The company’s commitment to research and development underpins its product innovation.
Sustainability & Growth Initiatives:
- Adopting circular economy practices in packaging and waste management
- Expanding enzyme portfolio to include novel proteases
- Collaborating with EU research consortia on enzyme engineering
Download FREE Sample Report: https://www.24chemicalresearch.com/download-sample/282326/global-pepsin-powder-market-2025-2032-645
Get Full Report: https://www.24chemicalresearch.com/reports/282326/global-pepsin-powder-market-2025-2032-645
🌍 Outlook: The Future of Global Pepsin Powder
The pepsin powder market is transitioning from a niche enzyme segment to a mainstream component in pharmaceutical and food production. This shift is underpinned by growing demand for peptide‑based therapeutics, rising consumer awareness of protein‑rich diets, and expanding regulatory frameworks that favor enzyme‑based processes.
📈 Key Trends Shaping the Market:
- Increasing adoption of high‑activity pepsin for rapid peptide synthesis in drug discovery
- Expansion of low‑activity pepsin in diagnostic enzyme kits
- Integration of digital manufacturing for real‑time quality control
- Strategic collaborations between enzyme producers and contract manufacturers to shorten time‑to‑market
These dynamics collectively reinforce the market’s upward trajectory, positioning leading players to capture new growth avenues across both developed and emerging economies.
- Top 10 Companies in the Isobutylene Isoprene Rubber (IIR) Market (2026): Market Leaders Powering Global Automotive and Healthcare - October 30, 2026
- Top 10 Companies in the E‑Textiles and Smart Clothing Market (2026): Market Leaders Driving Global Wearable Innovation - October 30, 2026
- Top 10 Companies in the United States Lithium Grease Market (2026): Market Leaders Driving U.S. Lubrication Trends - October 30, 2026
